Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint. (Q43724641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Eduard Parellada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Fernando Gutiérrez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

F Lomeña

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A M Catafau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Font

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J C Gómez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C López-Carrero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Pavía

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Salamero

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

87-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

A rating scale for drug-induced akathisia

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

The Mechanism of Action of Novel Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Limbic selectivity of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Chemical brain anatomy in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900085-3

7 January 2021

10.1016/S0925-4927(01)00085-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530275%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference